New pages
Jump to navigation
Jump to search
6 November 2026
- 12:3212:32, 6 November 2026 Autoimmune Encephalitis future or investigational therapies (hist | edit) [6,771 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis research is evaluating targeted immune treatments for patients with incomplete response to conventional therapy. Investigational treatment should be distinguished from established first- and second-line approaches. Published recommendations support specialist reassessment before rescue treatment because persistent disability does not necessarily...")
- 12:2812:28, 6 November 2026 Autoimmune Encephalitis cost-effectiveness of therapy (hist | edit) [5,863 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis can impose substantial hospital and long-term care costs. Published economic evidence includes resource-use studies and diagnostic-screening models, but these do not establish a universally most cost-effective immunotherapy.<ref name="Keller2026">Keller N, Bertram D, Hamer H, et al. [https://pubmed.ncbi.nlm.nih.gov/41998723/ Hospital resource use...")
- 12:1712:17, 6 November 2026 Autoimmune Encephalitis secondary prevention (hist | edit) [5,667 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis secondary prevention focuses on reducing relapse risk and recognizing recurrent disease after an initial episode. Follow-up and preventive treatment should reflect disease subtype, previous attacks, severity, and treatment risks. Long-term immunosuppression is not routinely recommended for every patient after a first presentation.<ref name="Hahn2...")
- 12:1212:12, 6 November 2026 Autoimmune Encephalitis primary prevention (hist | edit) [3,653 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis has no established disease-specific strategy that reliably prevents a first episode. Primary prevention concerns preventing disease before it develops; treatment of established encephalitis and prevention of relapse are separate issues. Expert information from Mayo Clinic emphasizes that consistent preventive measures for autoimmune causes of enc...")
- 12:0612:06, 6 November 2026 Autoimmune Encephalitis rehabilitation (hist | edit) [7,307 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis rehabilitation addresses physical, cognitive, communication, psychological, and participation difficulties after the acute illness. The 2024 Canadian consensus recommends screening for residual neuropsychiatric impairment and offering psychiatric care and neuropsychological rehabilitation when appropriate.<ref name="Hahn2024">Hahn C, Budhram A, A...")
- 11:5711:57, 6 November 2026 Autoimmune Encephalitis pediatric treatment considerations (hist | edit) [7,168 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis treatment in children requires pediatric neurology expertise, developmentally appropriate assessment, and individualized immunotherapy. The international pediatric treatment consensus specifically addresses N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis; its recommendations should not automatically be applied to every childhood infla...")
- 07:4407:44, 6 November 2026 Autoimmune Encephalitis surgery (hist | edit) [6,914 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis is primarily treated medically, but removal of an associated tumor can be an important component of treatment. Surgery is directed at the relevant neoplasm or a specific complication, rather than routine removal of brain tissue.<ref name="Abboud2021">Abboud H, Probasco JC, Irani S, et al. [https://pubmed.ncbi.nlm.nih.gov/33649022/ Autoimmune ence...")
- 07:3307:33, 6 November 2026 Autoimmune Encephalitis interventions (hist | edit) [8,123 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis may require therapeutic plasma exchange and procedures to manage respiratory failure, severe autonomic dysfunction, nutritional difficulties, or refractory catatonia. Interventions are selected according to disease severity and complications and should accompany appropriate immunotherapy and treatment of an associated neoplasm.<ref name="AbboudAc...")
- 07:2507:25, 6 November 2026 Autoimmune Encephalitis symptomatic and supportive therapy (hist | edit) [7,011 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis requires symptomatic and supportive treatment alongside immunotherapy and treatment of an associated tumor. Care aims to control seizures and distress, prevent complications, and restore function. Symptomatic improvement alone does not establish that inflammation has resolved.<ref name="AbboudLong2021">Abboud H, Probasco J, Irani SR, et al. [http...")
- 07:0207:02, 6 November 2026 Autoimmune Encephalitis medical therapy (hist | edit) [6,452 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis is a potentially life-threatening, treatable neurological illness. Medical therapy combines early immunotherapy, treatment of an associated tumor when present, and management of seizures and systemic complications. Treatment depends on diagnostic confidence, disease severity, antibody subtype, comorbidities, and response.<ref name="Michael2026">M...")
5 November 2026
- 21:5021:50, 5 November 2026 Autoimmune Encephalitis pediatric considerations (hist | edit) [8,033 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis in children requires assessment of developmental change and age-specific presentations. N-methyl-D-aspartate receptor (NMDAR) antibody encephalitis is the most common recognized neuronal antibody-mediated subtype in childhood. Pediatric diagnostic recommendations complement adult criteria; they are provisional classification criteria rather than...")
- 21:4021:40, 5 November 2026 Autoimmune Encephalitis screening for an associated neoplasm (hist | edit) [8,589 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis may occur with an underlying neoplasm, including a benign ovarian teratoma. Screening seeks a potentially relevant tumor; it does not mean that every patient has cancer. The 2024 Canadian consensus recommends initial neoplasm screening in all adults presenting with autoimmune encephalitis, without waiting for neuronal antibody results.<re...")
- 21:2421:24, 5 November 2026 Autoimmune Encephalitis other diagnostic studies (hist | edit) [7,437 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== In autoimmune encephalitis, additional diagnostic studies are selected according to the clinical phenotype, unresolved differential diagnosis, and residual symptoms. They may characterize cognitive impairment, identify peripheral nerve involvement or sleep disorders, or investigate an alternative disease. No single additional study independently confirms or excludes autoimmune encephalitis.<re...")
- 21:0321:03, 5 November 2026 Autoimmune Encephalitis electroencephalography (hist | edit) [11,042 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== In autoimmune encephalitis, electroencephalography (EEG) helps identify seizures, nonconvulsive status epilepticus, and focal or generalized cerebral dysfunction. Common abnormalities include background slowing and epileptiform discharges, but these are not specific for an autoimmune cause. A normal EEG does not exclude autoimmune encephalitis.<ref name="Hahn2024">Hahn C, B...")
- 20:4020:40, 5 November 2026 Autoimmune Encephalitis other imaging findings (hist | edit) [6,547 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== In autoimmune encephalitis, additional imaging may support the neurological assessment or identify an associated tumor. Brain '''fluorine-18 fluorodeoxyglucose positron emission tomography (18F-FDG PET)''' can be considered in selected diagnostically uncertain cases, including when magnetic resonance imaging (MRI) is normal or cannot be performed. An abnormal PET scan is not independently...")
- 20:0620:06, 5 November 2026 Autoimmune Encephalitis MRI (hist | edit) [10,562 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis may produce focal or multifocal abnormalities on magnetic resonance imaging (MRI), but a normal brain MRI does not exclude the disease. Imaging can support an inflammatory diagnosis, identify the anatomical pattern, and reveal alternative explanations for the presentation. Findings must be interpreted alongside the clinical course and other investigations.<ref name=...")
- 19:5419:54, 5 November 2026 Autoimmune Encephalitis CT (hist | edit) [5,736 bytes] Julinka Auta Fernandes (talk | contribs) (Created page with "__NOTOC__ {{CMG}} {{AE}} {{JAF}} {{Autoimmune encephalitis}} ==Overview== Autoimmune encephalitis has no specific diagnostic computed tomography (CT) appearance. Brain CT has limited sensitivity for autoimmune encephalitis, and a normal scan does not exclude the disease. In an acute presentation, head CT is principally useful for investigating alternative structural causes of symptoms or major intracranial complications.<ref name="Sanvito2024">Sanvito F, Pichiec...")